FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024 at 18:21 PM EDT
The FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are still trying to break into.
